Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Universal
Shanghai, Shanghai, Chinauniv-bio.com ↗
- Ownership
- Private
- Employees
- ~655
- Development stage
- Other
01
Overview
Shanghai Universal Biotech supplies antibodies, recombinant proteins, cytokines, and reagents for research use in academic, industrial, and hospital settings. The company does not conduct clinical therapeutic programs, but is a key supplier to the greater biotech ecosystem in China.
- Modalities
- AntibodyRecombinant proteinCytokineBiochemical reagentMolecular biology reagentCell biology reagent
- Industry
- Chemicals & Materials
02
Partnerships
Polyplus-Sartorius (distribution/antibody supply partnership)
Beyond the preview
Go deeper on Universal.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Universal.